menu
    • menu

    Company profile for Amring Pharma

    NEW Drugs in Dev: 1
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Amring sells uniquely positioned generics that bring value to customers and patients. We spend every minute of every day figuring out how to bring historically complex prescription medications to market. Our products are generics of value to the market, not high-volume, mass-produced products.We believe that we can deliver a better quality of life and health to the people in our communities, our families and the world.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Amring PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1205 Westlakes Dr., Suite 275 Berwyn, PA 19312
    Telephone
    Telephone
    844.304.4828
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.amringusa.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/amring-pharmaceuticals-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amring Appoints Eric D. Donnenfeld, MD as Medical Advisory Board Chair
    Amring Appoints Eric D. Donnenfeld, MD as Medical Advisory Board Chair

    26 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240226872185/en

    BUSINESSWIRE
    26 Feb 2024
    Share Share
    Nordic Pharma Completes Acquisition of Visant Medical
    Nordic Pharma Completes Acquisition of Visant Medical

    18 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231218603742/en

    BUSINESSWIRE
    18 Dec 2023
    Share Share
    Enforcement Report - Week of June 21, 2023
    Enforcement Report - Week of June 21, 2023

    21 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-21-2023-14473.pdf

    FDA
    21 Jun 2023
    Share Share
    Amring Pharmaceuticals Inc. Joins End Drug Shortages Alliance
    Amring Pharmaceuticals Inc. Joins End Drug Shortages Alliance

    29 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220629005664/en

    BUSINESSWIRE
    29 Jun 2022
    Share Share
    Amring Pharma Announces Launch of Timolol Maleate Ophthalmic Solution, USP 0.5%
    Amring Pharma Announces Launch of Timolol Maleate Ophthalmic Solution, USP 0.5%

    23 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220623005285/en

    BUSINESSWIRE
    23 Jun 2022
    Share Share
    Amring Pharma Bags Approval of Generic Lamotrigine Orally Disintegrating Tablets
    Amring Pharma Bags Approval of Generic Lamotrigine Orally Disintegrating Tablets

    14 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220214005785/en

    BUSINESSWIRE
    14 Feb 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search